Ibanez, B;
Aletras, AH;
Arai, AE;
Arheden, H;
Bax, J;
Berry, C;
Bucciarelli-Ducci, C;
... Fuster, V; + view all
(2019)
Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel.
Journal of the American College of Cardiology
, 74
(2)
pp. 238-256.
10.1016/j.jacc.2019.05.024.
Preview |
Text
Hausenloy_Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials_VoR.pdf - Published Version Download (3MB) | Preview |
Abstract
After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema, inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and ultimately replacement by fibrosis). The extension and magnitude of these changes contribute to long-term prognosis after MI. Cardiac magnetic resonance (CMR) is the gold-standard technique for noninvasive myocardial tissue characterization. CMR is also the preferred methodology for the identification of potential benefits associated with new cardioprotective strategies both in experimental and clinical trials. However, there is a wide heterogeneity in CMR methodologies used in experimental and clinical trials, including time of post-MI scan, acquisition protocols, and, more importantly, selection of endpoints. There is a need for standardization of these methodologies to improve the translation into a real clinical benefit. The main objective of this scientific expert panel consensus document is to provide recommendations for CMR endpoint selection in experimental and clinical trials based on pathophysiology and its association with hard outcomes.
| Type: | Article |
|---|---|
| Title: | Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.jacc.2019.05.024 |
| Publisher version: | https://doi.org/10.1016/j.jacc.2019.05.024 |
| Language: | English |
| Additional information: | © 2019 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an Open Access article under the CC BY-NC-ND License (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| Keywords: | STEMI, area at risk, clinical trial, edema, endpoint, infarct size, magnetic resonance imaging, myocardial infarction |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Pre-clinical and Fundamental Science |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10078159 |
Archive Staff Only
 |
View Item |
